Bacillus Calmette–Guerin (BCG) vaccine is usually given to newborn babies. Vaccination can be done from 6 months old to five years of age. According to World Health Organization, the annual risk of TB infection in children in high-burden countries is estimated to be 0.5-2%. Hence, BCG vaccines played an important role to protect newborns from tuberculosis and other similar diseases. This crucial factor is highly contributed to the growth of the global BCG vaccines market in the last few years.
Furthermore, increasing advancements in the vaccination camps. Also, solid campaigns in online and offline mode providing information to common people about proper vaccination in the current time. This important factor is expected to fuel the growth of the market. Also, the growing incidence of tuberculosis across the world and the rise in research activities for the development of the BCG vaccine are enhancing the market growth.
On the other hand, side effects and a global shortage of BCG vaccines may hamper the growth of the market. Besides, favorable government initiatives and a good focus on the vaccination programs globally are expected to open new opportunities for leading vendors of BCG vaccines in the forthcoming years.
BCG Vaccine Market Segment Overview
The immune BCG segment holds the highest share in the market. This is on account of the major role of BCG in effectively helping TB prevention and as of now, there is no substitute vaccine for immune BCG. In addition, several new vendors are focusing on developing new vaccinations for bladder cancer is anticipated to boost the market growth in the coming years.
BCG Vaccine Market Regional Overview
The market of the Asia Pacific is expected to grow at the fastest rate over the forecasted period. This is due to the high demand for BCG vaccines for the prevention of tuberculosis in the region. For instance, The Government of India has announced its plan to eliminate TB by 2025 during the Union Budget 2017–2018. Additionally, the market in Latin America and the Middle East, and Africa is expected to show noteworthy growth due to increasing awareness about the BCG vaccines.
BCG Vaccine Market Competitor overview
· In April 2020, the Serum Institute of India launched human trials to test the new BCG vaccine that can boost immunity in the fight against Covid-19.
BCG Vaccine Market, Key Players
· Intervax Ltd
· Greensignal Bio Pharma Limited
· AJ Vaccines
· China National Pharmaceutical Group Corporation
· Japan BCG Laboratory
· Greensignal Bio Pharma Limited
· Serum Institute of India Pvt. Ltd.
· Merck & Company Inc
· Sanofi S.A.
· Statens Serum Institute
· Gsbpl C
· Shanghai Institute of Biological Products
· Japan BCG Laboratory
BCG Vaccine Market Segmentation
BCG Vaccine Market, By Drug Type
· Immune BCG
· Therapy BCG
BCG Vaccine Market, By Usage
· Tuberculosis
· Bladder Cancer
BCG Vaccine Market, By End User
· Pediatrics
· Adults
BCG Vaccine market, By Region
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global BCG Vaccine Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Drug Type
- 5.2.1. Immune BCG
- 5.2.2. Therapy BCG
- 5.3. Market Analysis, Insights and Forecast – By Usage
- 5.3.1. Tuberculosis
- 5.3.2. Bladder Cancer
- 5.4. Market Analysis, Insights and Forecast – By End User
- 5.4.1. Pediatrics
- 5.4.2. Adults
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Latin America
- 5.5.3. Europe
- 5.5.4. Asia Pacific
- 5.5.5. Middle East and Africa
6. North America BCG Vaccine Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Drug Type
- 6.2.1. Immune BCG
- 6.2.2. Therapy BCG
- 6.3. Market Analysis, Insights and Forecast – By Usage
- 6.3.1. Tuberculosis
- 6.3.2. Bladder Cancer
- 6.4. Market Analysis, Insights and Forecast – By End User
- 6.4.1. Pediatrics
- 6.4.2. Adults
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Latin America BCG Vaccine Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Drug Type
- 7.2.1. Immune BCG
- 7.2.2. Therapy BCG
- 7.3. Market Analysis, Insights and Forecast – By Usage
- 7.3.1. Tuberculosis
- 7.3.2. Bladder Cancer
- 7.4. Market Analysis, Insights and Forecast – By End User
- 7.4.1. Pediatrics
- 7.4.2. Adults
- 7.5. Insights and Forecast – By Country
- 7.5.1. Brazil
- 7.5.2. Mexico
- 7.5.3. Rest of Latin America
8. Europe BCG Vaccine Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Drug Type
- 8.2.1. Immune BCG
- 8.2.2. Therapy BCG
- 8.3. Market Analysis, Insights and Forecast – By Usage
- 8.3.1. Tuberculosis
- 8.3.2. Bladder Cancer
- 8.4. Market Analysis, Insights and Forecast – By End User
- 8.4.1. Pediatrics
- 8.4.2. Adults
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. UK
- 8.5.2. Germany
- 8.5.3. France
- 8.5.4. Italy
- 8.5.5. Spain
- 8.5.6. Russia
- 8.5.7. Rest of Europe
9. Asia Pacific BCG Vaccine Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Drug Type
- 9.2.1. Immune BCG
- 9.2.2. Therapy BCG
- 9.3. Market Analysis, Insights and Forecast – By Usage
- 9.3.1. Tuberculosis
- 9.3.2. Bladder Cancer
- 9.4. Market Analysis, Insights and Forecast – By End User
- 9.4.1. Pediatrics
- 9.4.2. Adults
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. China
- 9.5.2. India
- 9.5.3. Japan
- 9.5.4. Australia
- 9.5.5. South East Asia
- 9.5.6. Rest of Asia Pacific
10. Middle East & Africa BCG Vaccine Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Drug Type
- 10.2.1. Immune BCG
- 10.2.2. Therapy BCG
- 10.3. Market Analysis, Insights and Forecast – By Usage
- 10.3.1. Tuberculosis
- 10.3.2. Bladder Cancer
- 10.4. Market Analysis, Insights and Forecast – By End User
- 10.4.1. Pediatrics
- 10.4.2. Adults
- 10.5. Market Analysis, Insights and Forecast – By Country
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Company Market Share Analysis, 2018
- 11.2. Key Industry Developments
- 11.3. Company Profile
- 11.4. Intervax Ltd
- 11.4.1. Business Overview
- 11.4.2. Segment 1 & Service Offering
- 11.4.3. Overall Revenue
- 11.4.4. Geographic Presence
- 11.4.5. Recent Development
- 11.5. Greensignal Bio Pharma Limited
- 11.6. AJ Vaccines
- 11.7. China National Pharmaceutical Group Corporation
- 11.8. Japan BCG Laboratory
- 11.9. Greensignal Bio Pharma Limited
- 11.10. Serum Institute of India Pvt. Ltd.
- 11.11. Merck & Company Inc
- 11.12. Sanofi S.A.
- 11.13. Statens Serum Institute
- 11.14. Gsbpl C
- 11.15. Shanghai Institute of Biological Products
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
